相似文献/References:
[1]李 勇,赵梦蕊,马爱霞,等.我国仿制药一致性评价对药品短缺的影响分析[J].卫生经济研究,2017,(05):47.
[2]盛亚楠,李 勇,马爱霞,等.我国短缺药品供应保障政策研究[J].卫生经济研究,2017,(08):57.
[3]葛 靖,王淑庆,常 峰,等.上海市短缺药品特点及使用变化情况研究[J].卫生经济研究,2020,(02):59.
GE Jing,WANG Shu-qing,CHANG Feng,et al.Study on the Characteristics and Changes of Drugs in Shortage in Shanghai[J].Journal Press of Health Economics Research,2020,(12):59.
[4]朱雅萌,傅鸿鹏.我国短缺药品现状分析与思考[J].卫生经济研究,2021,38(6):59.
ZHU Ya-meng,FU Hong-peng.Analysis and Reflection on the Current Situation of Drug Shortage in China[J].Journal Press of Health Economics Research,2021,38(12):59.
[5]俞心怡,吴 培,胡楠清,等.短缺药品储备政策的实施现状与优化——以江苏省为例[J].卫生经济研究,2021,38(11):29.
YU Xin-yi,WU Pei,HU Nan-qing,et al.Implementation Status and Optimization of Shortage Drug Reserve Policy——A Case Study of Jiangsu Province[J].Journal Press of Health Economics Research,2021,38(12):29.
[6]王丽娜,李亦蕾,王煜昊,等.我国短缺药品的采购方式及优化研究[J].卫生经济研究,2024,41(02):36.
WANG Lina,LI Yilei,WANG Yuhao,et al.Study on the Procurement Model and Optimization of Drug Shortage in China[J].Journal Press of Health Economics Research,2024,41(12):36.